PSI is excited to launch the Pharmacy-Based Immunization Delivery (PBID) project in Nigeria. This is part of a 4-year, 3-country pilot project funded by Takeda Pharmaceuticals that aims to demonstrate that pharmacies can safely and effectively deliver vaccines to those in need, with potential for rapid scalability. African governments are making significant efforts to achieve scale in immunization, despite the challenges of overburdened public health systems and setbacks from COVID-19. Yet across Africa, 30 million children under 5 suffer from vaccine preventable diseases and half a million children die each year. Vaccines are a low-cost, high-impact health intervention, and local pharmacies have effectively delivered vaccines in many countries. PBID is a new model in most countries in Africa and has the potential to support governments in expanding vaccine access to millions. Creating new service points will also be important during health emergencies like climate shocks and pandemics. The project will deliver vaccines to nearly 1M people, a majority of whom are women and girls. The evidence generated will create a blueprint to scale access to immunization across Africa.